• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT Back to Search Results
Catalog Number VS-402
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Pain (1994); Rash (2033); Ulceration (2116); Chills (2191); Sweating (2444); Patient Problem/Medical Problem (2688)
Event Date 05/03/2019
Event Type  Injury  
Manufacturer Narrative
(b)(4).If information is provided in the future, a supplemental report will be issued.
 
Event Description
It was reported that the patient had a venaseal carried out on the great saphenous vein(gsv), the short saphenous vein (ssv) and the anterior accessory great saphenous vein(aagsv) on (b)(6) 2019.It was reported that the patient has been returning to the physician between (b)(6) 2019 & (b)(6) 2019 complaining of a number of symptoms including redness and pain; tenderness to left leg; night sweats; chills; edema; maculopapular rash throughout body and spontaneous ulcerations.Treatment prescribed by provider has included voltaren gel; cephalosporin; hctz; clindamycin; furosemide & medrol dose packs.Last reported follow up visit, (b)(6), ultrasound showed closure of veins, still seeing spontaneous formation of wounds with no concerns over open varicosities.Patient was moving to idaho and has been instructed to keep in touch.
 
Manufacturer Narrative
Image review: images were returned for evaluation.Per the images, the patient access site exhibited multiple ulcers.Images 1 and 2 of the thigh in an area of the gsv exhibit ulceration and healing of the ulceration of the thigh over time.Images 3-5 shows evidence of visible purulent expressible discharge at the access cites of the ssv.Images 6-10 shows progressive healing of the wound over time.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Additional information: the length of vein treated in each case is reported as right gsv- 75cm, right ssv- 27cm, left gsv- 74cm, left ssv- 26cm.The patient is still in contact with the physician and is taking a heavy steroid with significant symptomatic improvement.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VENA SEAL CLOSURE SYSTEM
Type of Device
AGENT, OCCLUDING, VASCULAR, PERMANENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key8683180
MDR Text Key147471170
Report Number9612164-2019-02260
Device Sequence Number1
Product Code PJQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P140018
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 09/06/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberVS-402
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/05/2019
Initial Date FDA Received06/10/2019
Supplement Dates Manufacturer Received06/26/2019
09/05/2019
Supplement Dates FDA Received07/09/2019
09/06/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age77 YR
-
-